Skip to main content

Genetic Thrombophilias: When to Consider and What to Do

  • Chapter
  • First Online:
Practical Approach to the Management and Treatment of Venous Disorders

Abstract

The three aspects influencing risk of clotting—Virchow’s Triad—include venous stasis, vessel injury, and hypercoagulable states or thrombophilias (Fig. 13.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003;138:128–34.

    PubMed  Google Scholar 

  2. Cushman M. Inherited risk factors for venous thrombosis. Hematology Am Soc Hematol Educ Program. 2005;2005:452–7.

    Article  Google Scholar 

  3. Caprini JA, Glase CJ, Anderson CB, Hathaway K. Laboratory markers in the diagnosis of venous thromboembolism. Circulation. 2004;109(suppl I):I-4–8.

    CAS  Google Scholar 

  4. Moll S. Thrombophilias – practical implications and testing caveats. J Thromb Thrombolysis. 2006;21:7–15.

    Article  PubMed  Google Scholar 

  5. Kottke-Marchant K, Duncan A. Antithrombin deficiency: issues in laboratory diagnosis. Arch Pathol Lab Med. 2002;126:1326–36.

    PubMed  CAS  Google Scholar 

  6. Dager WE, Gosselin RC, Owings JT. Argatroban therapy for antithrombin deficiency and mesenteric thrombosis: case report and review of the literature. Pharmacotherapy. 2004;24:659–63.

    Article  PubMed  Google Scholar 

  7. Goodwin AJ, Rosendaal FR, Kottke-Marchant K, Bovill E. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med. 2002;126:1349–66.

    PubMed  CAS  Google Scholar 

  8. Press RD, Bauer KA, Kujovich JL, Heit JA. Clinical utility of factor V Leiden (R506Q) testing for the diagnosis and management of thromboembolic disorders. Arch Pathol Lab Med. 2002;126:1304–18.

    PubMed  Google Scholar 

  9. McGlennen RC, Key NS. Clinical and laboratory management of the prothrombin G20210A mutation. Arch Pathol Lab Med. 2002;126:1319–25.

    PubMed  CAS  Google Scholar 

  10. Chandler WL, Rodgers GM, Sprouse JT, Thompson AR. Elevated hemostatic factor levels as potential risk factors for thrombosis. Arch Pathol Lab Med. 2002;126:1405–14.

    PubMed  CAS  Google Scholar 

  11. Key NS, McGlennen RC. Hyperhomocyst(e)inemia and thrombophilia. Arch Pathol Lab Med. 2002;126:1367–75.

    PubMed  CAS  Google Scholar 

  12. Bønaa KH, Njølstad I, Ueland PM, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–88.

    Article  PubMed  Google Scholar 

  13. Den Heijer M, Willems HPJ, Blom HJ, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism: a randomized, placebo-­controlled, double blind trial. Blood. 2007;109:139–44.

    Article  Google Scholar 

  14. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–77.

    Article  Google Scholar 

  15. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the vitamin intervention for stroke prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–75.

    Article  PubMed  CAS  Google Scholar 

  16. Brandt J. Plasminogen and tissue-type plasminogen activator deficiency as risk factors for thromboembolic disease. Arch Pathol Lab Med. 2002;126:1376–81.

    PubMed  CAS  Google Scholar 

  17. Francis CW. Plasminogen activator inhibitor-1 levels and polymorphisms: association with venous thromboembolism. Arch Pathol Lab Med. 2002;126:1401–4.

    PubMed  CAS  Google Scholar 

  18. Hayes T. Dysfibrinogenemia and thrombosis. Arch Pathol Lab Med. 2002;126:1387–90.

    PubMed  Google Scholar 

  19. Kitchens C. The contact system. Arch Pathol Lab Med. 2002;126:1382–6.

    PubMed  Google Scholar 

  20. Tollefsen DM. Heparin cofactor II deficiency. Arch Pathol Lab Med. 2002;126:1394–400.

    PubMed  CAS  Google Scholar 

  21. Dalen JE. Should patients with venous thromboembolism be screened for thrombophilia ? Am J Med. 2008;121:458–63.

    Article  PubMed  Google Scholar 

  22. Ho WK, Hankey GJ, Quinlan DJ, Eikelboom JW. Risk of recurrent venous thromboembolism in patients with common thrombophilia. Arch Intern Med. 2006;166:729–36.

    Article  PubMed  CAS  Google Scholar 

  23. Kearon C, Kahn SR, Agnelli G. Antithrombotic therapy for venous thromboembolic disease. Chest. 2008;133:454S–545.

    Article  PubMed  CAS  Google Scholar 

  24. Van Cott EM, Laposata M, Prins MH. Laboratory evaluation of hypercoagulability with venous or arterial thrombosis. Arch Pathol Lab Med. 2002;126:1281–95.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edith A. Nutescu Pharm.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Nutescu, E.A., Michaud, J.B., Caprini, J.A., Caprini, J.A. (2013). Genetic Thrombophilias: When to Consider and What to Do. In: Sadick, N., Khilnani, N., Morrison, N. (eds) Practical Approach to the Management and Treatment of Venous Disorders. Springer, London. https://doi.org/10.1007/978-1-4471-2891-5_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2891-5_13

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2890-8

  • Online ISBN: 978-1-4471-2891-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics